Pozna{umlaut over (n)}, Poland

Natalia Kleczewska


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Natalia Kleczewska

Introduction

Natalia Kleczewska is a prominent inventor based in Poznań, Poland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with potential anticancer properties. Her work is characterized by a strong focus on innovative solutions to pressing health challenges.

Latest Patents

Kleczewska holds a patent for her invention titled "2', 5′-dideoxy-5-fluorouridine derivatives having cytotoxic activity, a process for the manufacture thereof and application thereof." This patent describes novel 2',5′-dideoxy-5-fluorouridine derivatives that exhibit cytotoxic activity. The invention includes a process for manufacturing these derivatives and their application in treating various types of cancer, including breast cancer, cervical cancer, lung cancer, and nasopharynx cancer.

Career Highlights

Kleczewska is affiliated with Adam Mickiewicz University, where she conducts her research and development activities. Her academic background and research expertise have positioned her as a key figure in her field. She has dedicated her career to exploring innovative therapeutic options that can improve patient outcomes in oncology.

Collaborations

Kleczewska has collaborated with notable colleagues, including Lech Celewicz and Karol Kacprzak. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.

Conclusion

Natalia Kleczewska's work exemplifies the impact of innovative research in the fight against cancer. Her contributions to medicinal chemistry and her dedication to developing effective treatments highlight the importance of continued innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…